CLINICIANS
RESEARCH

Research-Backed Parkinson’s Speech and Voice Technology

SpeechVive users diagnosed with dysarthria and Parkinson’s experience similar outcomes to other Parkinson’s speech treatment and voice therapy.

Recent research publications citing the technology of SpeechVive and its impact on Parkinson’s patient speech improvements.

publication icon

Increases sound pressure levels an average of +3dB in conversational speech (approximately a 50% gain in perceptual volume).

publication icon

Compares to LSVT Loud™ with similar improvements to sound pressure level and decreased in pause duration post-tx.

publication icon

Significantly increases speech intelligibility

publication icon

Improves vocal intensity, pausing, utterance length, and intonational contrast leading to overall communication improvement.

publication icon

Users do not habituate to the sound cue

publication icon

Use of SpeechVive during everyday communication lead to improved temporal coordination across laryngeal and supralaryngeal mechanisms for the majority of speakers

publication icon

The sound cue in SpeechVive elicitied the highest sound pressure levels for both epople with Parkinson’s and age-matched peers

publication icon

Participants with deep brain stimulation devices (DBS) showed the same patterns of improvement as participants without DBS